BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fink DM, Steele MM, Hollingsworth MA. The lymphatic system and pancreatic cancer. Cancer Lett 2016;381:217-36. [PMID: 26742462 DOI: 10.1016/j.canlet.2015.11.048] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Lin J, Wang W, Chen H, Deng X, Peng C, Cheng D, Shen B. Should a standard lymphadenectomy include the No. 9 lymph nodes for body and tail pancreatic ductal adenocarcinoma? Pancreatology 2019;19:414-8. [DOI: 10.1016/j.pan.2019.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Fu Z, Chen C, Zhou Q, Wang Y, Zhao Y, Zhao X, Li W, Zheng S, Ye H, Wang L, He Z, Lin Q, Li Z, Chen R. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Cancer Lett 2017;410:68-81. [PMID: 28947139 DOI: 10.1016/j.canlet.2017.09.019] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 19.2] [Reference Citation Analysis]
3 Li M. Clinical practice guidelines for the interventional treatment of advanced pancreatic cancer (5th edition). Journal of Interventional Medicine 2021;4:159-71. [DOI: 10.1016/j.jimed.2021.08.001] [Reference Citation Analysis]
4 Selvanesan BC, Meena K, Beck A, Meheus L, Lara O, Rooman I, Gravekamp C. Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice. J Immunother Cancer 2020;8:e001250. [PMID: 33154149 DOI: 10.1136/jitc-2020-001250] [Reference Citation Analysis]
5 Hoshikawa M, Ogata S, Nishikawa M, Kimura A, Einama T, Noro T, Aosasa S, Hase K, Tsujimoto H, Ueno H, Yamamoto J. Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer. Medicine (Baltimore) 2019;98:e14369. [PMID: 30702628 DOI: 10.1097/MD.0000000000014369] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
6 Gasparini G, Pellegatta M, Crippa S, Lena MS, Belfiori G, Doglioni C, Taveggia C, Falconi M. Nerves and Pancreatic Cancer: New Insights into a Dangerous Relationship. Cancers (Basel) 2019;11:E893. [PMID: 31248001 DOI: 10.3390/cancers11070893] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
7 Waldeland JO, Gaustad JV, Rofstad EK, Evje S. In silico investigations of intratumoral heterogeneous interstitial fluid pressure. J Theor Biol 2021;526:110787. [PMID: 34087266 DOI: 10.1016/j.jtbi.2021.110787] [Reference Citation Analysis]
8 Byun Y, Lee KB, Jang JY, Han Y, Choi YJ, Kang JS, Kim H, Kwon W. Peritumoral lymph nodes in pancreatic cancer revisited; is it truly equivalent to lymph node metastasis? J Hepatobiliary Pancreat Sci 2021. [PMID: 33735543 DOI: 10.1002/jhbp.940] [Reference Citation Analysis]
9 Sun J, Russell CC, Scarlett CJ, McCluskey A. Small molecule inhibitors in pancreatic cancer. RSC Med Chem 2020;11:164-83. [PMID: 33479626 DOI: 10.1039/c9md00447e] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
10 Shen CN, Goh KS, Huang CR, Chiang TC, Lee CY, Jeng YM, Peng SJ, Chien HJ, Chung MH, Chou YH, Hsieh CC, Kulkarni S, Pasricha PJ, Tien YW, Tang SC. Lymphatic vessel remodeling and invasion in pancreatic cancer progression. EBioMedicine 2019;47:98-113. [PMID: 31495721 DOI: 10.1016/j.ebiom.2019.08.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
11 Lohrmann C, O'Reilly EM, O'Donoghue JA, Pandit-Taskar N, Carrasquillo JA, Lyashchenko SK, Ruan S, Teng R, Scholz W, Maffuid PW, Lewis JS, Weber WA. Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer. Clin Cancer Res 2019;25:7014-23. [PMID: 31540979 DOI: 10.1158/1078-0432.CCR-18-3667] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 6.7] [Reference Citation Analysis]
12 Andersen LMK, Wegner CS, Simonsen TG, Huang R, Gaustad JV, Hauge A, Galappathi K, Rofstad EK. Lymph node metastasis and the physicochemical micro-environment of pancreatic ductal adenocarcinoma xenografts. Oncotarget 2017;8:48060-74. [PMID: 28624797 DOI: 10.18632/oncotarget.18231] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
13 Renard Y, Perrenot C, Labrousse M, Avisse C, Rhaiem R, Piardi T, Braun M, Perez M. Exploration of peripancreatic lymphatic pathways in a live porcine model. Ann Anat 2019;225:57-64. [PMID: 31284072 DOI: 10.1016/j.aanat.2019.06.003] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Judge SM, Nosacka RL, Delitto D, Gerber MH, Cameron ME, Trevino JG, Judge AR. Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival. JNCI Cancer Spectr 2018;2:pky043. [PMID: 30637373 DOI: 10.1093/jncics/pky043] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
15 Wei Y, Shi D, Liang Z, Liu Y, Li Y, Xing Y, Liu W, Ai Z, Zhuang J, Chen X, Gao Q, Jiang J. IL-17A secreted from lymphatic endothelial cells promotes tumorigenesis by upregulation of PD-L1 in hepatoma stem cells. J Hepatol. 2019;71:1206-1215. [PMID: 31499129 DOI: 10.1016/j.jhep.2019.08.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
16 Wang S, Shi H, Yang F, Teng X, Jiang B. The value of 18F-FDG PET/CT and carbohydrate antigen 19-9 in predicting lymph node micrometastases of pancreatic cancer. Abdom Radiol (NY) 2019;44:4057-62. [PMID: 31570958 DOI: 10.1007/s00261-019-02248-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Selvanesan BC, Chandra D, Quispe-Tintaya W, Jahangir A, Patel A, Meena K, Alves Da Silva RA, Friedman M, Gabor L, Khouri O, Libutti SK, Yuan Z, Li J, Siddiqui S, Beck A, Tesfa L, Koba W, Chuy J, McAuliffe JC, Jafari R, Entenberg D, Wang Y, Condeelis J, DesMarais V, Balachandran V, Zhang X, Lin K, Gravekamp C. Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice. Sci Transl Med 2022;14:eabc1600. [PMID: 35320003 DOI: 10.1126/scitranslmed.abc1600] [Reference Citation Analysis]
18 Zhao T, Xu Y, Ren S, Liang C, Zhou X, Wu J. The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells. Exp Ther Med 2018;15:4370-8. [PMID: 29725377 DOI: 10.3892/etm.2018.5964] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Wang S, Zheng Y, Yang F, Zhu L, Zhu XQ, Wang ZF, Wu XL, Zhou CH, Yan JY, Hu BY, Kong B, Fu DL, Bruns C, Zhao Y, Qin LX, Dong QZ. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduct Target Ther 2021;6:249. [PMID: 34219130 DOI: 10.1038/s41392-021-00659-4] [Reference Citation Analysis]
20 Shi X, Guo X, Li X, Wang M, Qin R. Loss of Linc01060 induces pancreatic cancer progression through vinculin-mediated focal adhesion turnover. Cancer Lett 2018;433:76-85. [PMID: 29913236 DOI: 10.1016/j.canlet.2018.06.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
21 Gore J, Imasuen-Williams IE, Conteh AM, Craven KE, Cheng M, Korc M. Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model. Cancer Lett 2016;379:143-53. [PMID: 27267807 DOI: 10.1016/j.canlet.2016.05.037] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
22 Renard Y, de Mestier L, Balaj C, Arnoux JM, Labrousse M, Hossu G, Perez M. A radio-anatomical correlation study of the cisterna chyli. J Anat 2018;233:679-84. [PMID: 30101484 DOI: 10.1111/joa.12869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
23 Dai M, Zhang H, Li Y, Xing C, Ding C, Liao Q, Zhang T, Guo J, Xu Q, Han X, Liu W, Liu Q. Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatosplenectomy (CDPS) for left-sided pancreatic ductal adenocarcinoma. Surg Today 2021;51:1126-34. [PMID: 33389192 DOI: 10.1007/s00595-020-02203-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Sun J, Ambrus JI, Baker JR, Russell CC, Cossar PJ, Sakoff JA, Scarlett CJ, McCluskey A. 3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active lead. Investigation of the terminal aromatic moiety. Bioorg Med Chem Lett 2022;:128591. [PMID: 35114371 DOI: 10.1016/j.bmcl.2022.128591] [Reference Citation Analysis]
25 Li H, Pan W, Xu L, Yin D, Cheng S, Zhao F. Prognostic Significance of Microvascular Invasion in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis. Med Sci Monit 2021;27:e930545. [PMID: 34393219 DOI: 10.12659/MSM.930545] [Reference Citation Analysis]